Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patientsPhilosophical Transactions of the Royal Society B: Biological Sciences · 2026-11-10A multi-institutional investigation of psilocybin's effects on mouse behavior.Nature neuroscience · 2026-11-02Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.The International journal of eating disorders · 2026-11-01Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.Psychopharmacology · 2026-09-15HORMONAL MODULATION OF PSILOCYBIN RESPONSIVITY ACROSS THE FEMALE REPRODUCTIVE LIFESPANInternational Journal of Innovative Technologies in Social Science · 2026-08-31PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALSInternational Journal of Innovative Technologies in Social Science · 2026-08-31Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17Synthesis and Biological Evaluation of 4-Bromo-dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.ACS omega · 2026-07-07THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026-06-01Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic ReviewPsyArXiv · 2026-05-24Human brain changes after first psilocybin useNature Communications · 2026-05-05Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-17Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-17Psilocybin: Wirksam, aber kein WundermittelMMW - Fortschritte der Medizin · 2026-04-01Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.Expert opinion on pharmacotherapy · 2026-04-01Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.BMJ open · 2026-03-12Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.BJPsych open · 2026-02-16PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSIONInternational Journal of Innovative Technologies in Social Science · 2026-01-28Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-20Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.Therapeutic advances in psychopharmacology · 2026-01-01Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in psychiatry and psychotherapy · 2025-12-17Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover TrialPsyArXiv · 2025-11-16PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCHInternational Journal of Innovative Technologies in Social Science · 2025-09-01Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.The Australian and New Zealand journal of psychiatry · 2025-09-01Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.International journal of molecular sciences · 2025-07-26Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-07-01Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.JAMA network open · 2025-07-01Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.Expert opinion on emerging drugs · 2025-06-01Further education in psychedelic-assisted therapy - experiences from Switzerland.BMC medical education · 2025-03-05Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.Clinical neuropharmacology · 2025-01-01Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.Neuroscience applied · 2025-01-01Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.Journal of eating disorders · 2024-12-27Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.Journal of psychopharmacology (Oxford, England) · 2024-10-01Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for DepressionPsychoactives · 2024-04-15Psychedelika-assistierte PsychotherapieDie Psychotherapie · 2024-02-28Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse modelNeuroscience Applied · 2024-01-01Cannabis and Psilocybin: Insurance Reimbursement, Legalization, and ReschedulingHealth Law Outlook · 2024-01-01Is there credible evidence to assert psilocybin-assisted therapy for depression?European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2024-01-01Psychedelics and cognitive function: A systematic reviewResearch Society and Development · 2023-12-13use of psilocybin in the treatment of psychiatric disorders - reviewJournal of Education Health and Sport · 2023-08-15Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.International journal of environmental research and public health · 2023-01-19A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.Journal of analytical toxicology · 2022-07-14Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.Substance abuse treatment, prevention, and policy · 2022-05-14Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discriminationForensic Chemistry · 2022-04-08Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.Frontiers in pharmacology · 2022-01-013,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.Frontiers in psychiatry · 2022-01-01Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-19Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.Frontiers in psychiatry · 2021-01-01LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in pharmacology · 2017-01-01Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in MiceToxins · 2015-03-27[Alteration of music perception in experimental psychosis (psilocybin)].Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie · 1967-01-01